Lower-Income Strain, Pancreatic Cancer Breakthrough

Key takeaways

• Lower-income adults near retirement face growing financial strain before benefits begin.
• Positive attitudes toward aging may support better mental and physical function later.
• A new pancreatic cancer drug doubled survival time in a clinical trial.

Summary

Lower-income strain and pancreatic cancer advances are the focus of this update, which highlights financial stress in preretirement adults and promising health research. Adults in their 50s and early 60s report increasing difficulty covering essentials like food, bills and savings, with delayed access to Medicare and Social Security contributing to the burden.

At the same time, new findings challenge common assumptions about aging, showing many older adults maintain or improve their physical and mental function, especially with a positive outlook. Researchers also report encouraging results from a clinical trial of a new pancreatic cancer drug, which extended survival and improved quality of life for patients with advanced disease.

The key takeaways and summary were created with the assistance of generative AI. An AARP editor reviewed and refined the content for accuracy and clarity.

Full transcript

[0:00:04] Lower income adults in their 50s and early 60s are feeling greater financial

[0:00:08] strain than older age groups that are eligible for Social Security and Medicare,

[0:00:13] according to a new AARP Foundation survey.

[0:00:17] Many are struggling to cover food, bills and savings, with two-thirds saying they find it difficult to get by.

[0:00:24] Experts say delayed access to Medicare and Social Security may be adding to the pressure.

[0:00:31] A new Yale study challenges the idea that aging always means decline.

[0:00:36] Researchers found nearly half of adults 65 and older actually improved physical and mental function over time, especially for those with positive views on aging.

[0:00:47] Experts say the findings show that getting older isn’t a single path.

[0:00:53] A new pancreatic cancer drug may bring hope for one of the deadliest cancers.

[0:00:58] In a clinical trial, the pill, daraxonrasib, doubled the survival time for patients with advanced pancreatic cancer.

[0:01:06] Participants also reported less pain and better quality of life than with other treatments.

[0:01:10] Almost all cases of pancreatic cancer are found in adults 45 and older.